Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
EXPRS2.STthis companyExpreS2ion Biotech Holding AB (publ)	SEK 0.93	-1.19×	1.27×	12.37×	0×	1336.2%	-1171.5%	-1444.4%	-1041.4%	-106.7%	-121.9%	-90.4%	0.06×	0.88×	-117.12×	2.04×	0.0%	2	-2.66	3	B
ACOU.STAcouSort AB	SEK 3.12	-4.42×	3.27×	7.79×	-3.29×	-1703.2%	-211.6%	-211.6%	-177.3%	-74.6%	-89.0%	-32.4%	0×	0.44×	-10.85×	8.19×	0.0%	2	-4.93	1	D+
AINO.STAino Health AB (publ)	SEK 0.18	-5.72×	-5.45×	1.34×	-11.4×	9.1%	-16.4%	-20.0%	-23.4%	95.1%	-278.5%	-6.9%	-1.3×	-0.77×	-6.08×	0.89×	0.0%	3	-0.85	2	C
FLUI.STFluicell AB (publ)	SEK 25.90	-1.65×	1.26×	2.29×	-1.38×	-381.5%	-144.7%	-144.7%	-138.8%	-76.4%	-79.7%	-99.1%	0×	0.27×	-45×	1×	0.0%	3	-3.05	3	B+
MODTX.STModus Therapeutics Holding AB	SEK 0.17	-1.01×	2.1×	0×	-0.42×	4.5%	0.0%	0.0%	0.0%	-204.4%	-200.3%	-94.9%	0×	0.63×	-45.3×	3.51×	0.0%	1	-38.3	2	C
ONCOZ.STOncoZenge AB (publ)	SEK 3.20	-5.16×	-139.7×	30.78×	-5.41×	-72.6%	-181.7%	-595.7%	-598.3%	2715.5%	-229.6%	-15.9%	-12.78×	-0.24×	-93.91×	1.01×	0.0%	2	-18.16	2	C
Peer median	—	-4.42×	1.26×	2.29×	-3.29×	-72.6%	-144.7%	-144.7%	-138.8%	-74.6%	-200.3%	-32.4%	0×	0.27×	-45×	1.01×	0.0%	2	-4.93	2	—